CLOV Form 144: Proposed sale of 5,833 RSUs

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the proposed sale of 5,833 Restricted Stock Units on 03/14/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting the proposed sale of 5,833 Restricted Stock Units on 03/14/2026. The filing also discloses prior 10b5-1 sales by Jamie Reynoso: 4,597 shares on 01/20/2026 and 2,102 shares on 01/07/2026, with reported dollar amounts of 11,871.75 and 5,319.32, respectively.

Insights

Corporate Governance Analyst

Form 144 lists a proposed sale of 5,833 RSUs and two recent 10b5-1 sales by Jamie Reynoso.

The filing records a proposed sale of 5,833 Restricted Stock Units dated 03/14/2026. It also documents two executed 10b5-1 dispositions: 4,597 shares on 01/20/2026 and 2,102 shares on 01/07/2026, with the dollar figures shown in the excerpt.

These entries are routine notice filings under resale rules; cash outcomes and further execution details are not provided in the excerpt. Subsequent public filings would show completion or proceeds if and when sales occur.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLOV Form 144 report?

The filing reports a proposed sale of 5,833 Restricted Stock Units dated 03/14/2026. It also lists two prior 10b5-1 sales by Jamie Reynoso: 4,597 and 2,102 shares on 01/20/2026 and 01/07/2026.

Who is listed as the seller on the CLOV Form 144?

Morgan Stanley Smith Barney LLC is named as the filer for the proposed RSU sale. The executed 10b5-1 sales are attributed to Jamie Reynoso in the excerpt, with addresses shown for reporting purposes.

How many shares were sold under the 10b5-1 plans in the excerpt?

The excerpt shows two 10b5-1 sales totaling 6,699 shares: 4,597 shares on 01/20/2026 and 2,102 shares on 01/07/2026, with accompanying dollar figures in the filing.

Do the Form 144 entries confirm cash proceeds to the issuer?

The excerpt does not state who receives proceeds. The entries list share counts and dollar figures for executed sales; the filing does not attribute proceeds to the issuer or selling holders in the provided text.

Are the reported sales described as 10b5-1 transactions?

Yes. The two executed dispositions by Jamie Reynoso in January are labeled as 10b5-1 Sales on the filing, indicating they were made under a prearranged trading plan as disclosed in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839066
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	JAMIE REYNOSO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5833	11257.69	428951430	03/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/14/2026	Restricted Stock Units	Issuer			5833	03/14/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	01/20/2026	4597	11871.75
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	01/07/2026	2102	5319.32

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 03/14/2026 through 03/15/2026.
Date of Notice	03/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jamie Reynoso
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)